Bioguard extends services by developing COVID- 19 diagnostic kits

Amidst the crisis caused by the COVID- 19 spreading globally, Bioguard Corporation, as a leading corporation in biotechnology industry, extends its services by developing COVID- 19 diagnostic kits to help in the fast detection of infected people and help in the containment of the disease . The Bioguard considers the health and safety of people as a top priority. The company is continuously providing services and manufacturing diagnostic kits. Providing as efficient and accurate diagnostic kits to companion animals, the Bioguard Corporation mobilized its diagnostic laboratory to aid the need of fast and reliable detection in fighting COVID- 19 by putting effort in developing qPCR reagents for the detection of the COVID- 19 and is currently on progress. The company ensures that the quality and accuracy of the results shall be maintained. Updates shall be posted. For the meantime, the Bioguard Corporation reminds everyone to stay safe and cooperate with the authorities’ instruction to protect yourself from the disease.
Bioguard will participate the global BIO Digital 2020

The Bioguard Corporation, as a part of Taiwan Pavilion, will be participating the BIO Digital 2020, and will be representing Taiwan for the event on June 8 -12, 2020.The BIO International Convention is the biggest worldwide biological conventions in North America being held yearly to showcase innovations from different companies across the world in which Bioguard Corporation actively participates. This is the second time that the company will participate in the said event. However, due to the current pandemic, the convention will be in a new virtual event format, BIO Digital.The Biotechnology Innovation Organization (BIO) announces to change the strategy of bringing global biotech industries participating BIO International Convention 2020, including Bioguard Corporation, into BIO Digital wherein convention would be held virtual.The BIO Digital will present BIO One-on-One Partnering, Online Education, and On-Demand Company Presentations. This will enable new features of potential partnerships of different companies. This event promotes non- stop innovation despite the current global situation.
Bioguard Corporation Collaborates with Cytiva

Bioguard Corporation- with its dedication in providing thorough animal disease diagnostic services and manufacturing efficient and accurate diagnostic test kits, plans to collaborate with Cytiva. In line with the Bioguard’s motto, “Science for animal care”, our company’s dedication to protecting animal health with our technologies and accurate, professional help should be a priority. On the other hand, the Cytiva, previously GE Healthcare Life Sciences, is a known global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. The Cytiva has always been a partner to Bioguard in providing advanced technologies but this time, the two companies are planning to expand their partnership to further accelerate productivity while assuring quality and accurate results. The collaboration is expected to provide innovation and advanced technology to augment the increasing demand for fast and reliable veterinary health diagnostics.
Bioguard Launches New Diagnostic Service: Canine Neosporosis

The Bioguard Corporation launches their newest diagnostic service available for canine neosporosis caused by Neospora caninum. With the threat it causes to dog pets, Bioguard’s built-in laboratory in Taiwan accepts samples for testing. The laboratory runs blood or feces samples under qPCR to check the presence of the parasite. The parasite N. caninum is the causative agent for neosporosis, which is an important neuromuscular disease in dogs. The N. caninum is an obligate, intracellular, coccidian, protozoan parasite which causes infection in both dogs as a definitive host, and herbivore intermediate hosts , usually cattle. The disease severely infects young puppies causing paralysis of rear limbs, and is often progressive. Infected adult dogs show neurologic signs, pneumonia, and inflammations in skin, liver, and heart are possible. The corporation, since establishment, has always been a partner of veterinarians in fast and accurate diagnosis of different companion animal diseases.
Bioguard Supports Local Vets through Continuous In- Hospital Education

The Bioguard Corporation conducts in- hospital education courses, headed by Robert Lo, Ph.D./DVM, to extend support to the local veterinarians through sharing knowledge on different pet diseases. Pursuant to the corporation’s dedication in providing professional help, Dr. Robert shares his expertise with the local veterinarians. He visits veterinary hospitals on a weekly basis to impart knowledge and contribute in improving their professional capability. The previous visits to the local vets has boosted their confidence and widened their knowledge on different pet diseases. Therefore, the continuous training is expected to provide stronger support to the local veterinarians and explore more insights in a veterinary aspect.
Bioguard Announces Participation in 12th WESAVC

The Bioguard Corporation will be joining the 12 th East and West Small Animal Clinical Veterinary Conference on July 21- 23, 2020. The said conference is one of the biggest events for small animal veterinary, and is held yearly in China. With the number of participants increasing every year, 2019 participants reached 14,535 in total. It is participated by exhibitors all over the world. Small animal clinical experts and specialists are also invited to give professional talks in the field. The exhibit includes industries of pet medical, pet foods, and pet supplies. Over all, the event is expected to build a platform of science and technology communication for small animal veterinarian, to facilitate the continuous education development for small animal veterinarian, promoting small animal clinical veterinary technology with international standards, and enhancing over- all level of Chinese small animal veterinarian.
Bioguard will be Launching a Book on Veterinary Clinical Bacterial Diseases and Antibiotics

The Bioguard Corporation has set to release their veterinary book on this coming July, 2020. The contents of the book were contributed by Dr. Cheng-Yi Lin (林政毅), Chairman of Taiwan Society of Feline Medicine; Dr. Chen-Si Lin (林辰栖), Professor of National Taiwan University; Dr. Shengteng Luo (罗胜腾), Director of HongChang Animal hospital; and the veterinary specialists from the Bioguard. It covers fields related to bacteriology and antibiotics specifically to companion animals. It contains figures and descriptions of different pathogens in dogs and cats, diseases they cause including symptoms, diagnosis, and disease managements. This book will be exclusively published by Bioguard in Taiwan and China first, for the partner local veterinarians. Availability in book stores shall be announced after its official launching. This is expected to impart knowledge and serve as reference for veterinarians on the causative agents of companion animal diseases.
Bioguard’s Participation in 12th WESAVC was Rescheduled

The Bioguard Corporation’s participation for the 12 th East and West Small Animal Clinical Veterinary Conference was rescheduled on November 24- 26, 2020 due to the COVID19 pandemic. Bioguard has been participating in the event every year and showcases the high quality veterinary products that we developed and manufacture. However, the WESAVA has announced the postponement of the conference for the year 2020, in relation with the current global status amidst the COVID19 pandemic. The WESAVC is yearly held in China as one of the biggest events for small animal veterinary, participated by increasing number of exhibitors all over the world. Professional talks are being given by clinical experts and specialists in small animal veterinary during the conference. Industries related to small animals: pet medical; pet foods; and pet supplies are expected to gather and bridge the gap in communicating and providing innovative technology for the small animal veterinary. Given the circumstances, everyone is reminded to stay safe and healthy.
Bioguard Attends 19th Second General Meeting of TCVA

The Bioguard Corporation has attended the 19th Second General Meeting and Continuing Education and Training of Veterinarians on July 26, 2020 at Beitun District, Taichung City. Strictly following the COVID 19 prevention measures, members of the TCVA gathered. Booths were installed to display different veterinary products. In Bioguard’s post, high quality veterinary diagnostic kits were showcased. Stationed also were the corporation’s veterinary experts to provide professional assistance to visiting participants of the said event. The annual gathering of the association strengthens the veterinary industry in Taiwan, specifically in Taichung City.
Bioguard will Host Online Veterinary Courses on September 2020

The Bioguard Corporation will be launching Online Veterinary Courses starting first week of September, with Yung- Tsun Lo, DVM, PhD, one of the corporation’s veterinary experts, giving the lectures. Dr. Lo finished his PhD Degree in Mississippi State University, College of Veterinary Medicine on 2007. After working in College of Veterinary Medicine in University of Florida and afterwhich in Institute of Molecular Biology, Academia Sinica, Taiwan as Post-Doctoral Fellow, he joined Bioguard in 2016. He will share lectures in his fields of expertise: virology, immunology, molecular biology and clinical microbiology during the online courses. In addition to, Dr. Lo, together with his team, visits local veterinary clinics to conduct In- hospital lectures to the local veterinarians. These programs of the company are in line with the mission of providing not only high quality veterinary diagnostic kits but also extending professional support to our veterinarians. Meanwhile, schedule and topics of his lectures will be announced in the coming weeks. Stay In- tune.